Financials
- Market Capitalization 1.67 B
- Employee 970
- Founded 2001
- CEO N/A
- Website www.anipharmaceuticals.com
- Headquarter Delaware, United States
- FIGI BBG000KK1L04
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2003 | PRGO Perrigo Company plc Ordinary Shares | 14.49 USD | +0.76% | +2.19% | +40.27% | -32.67% | 2.01 B USD | ||
| 2120 | ETON Eton Pharmaceuticals, Inc. - Common Stock | 59.78 USD | -4.61% | -6.59% | +21.78% | +250.62% | 1.71 B USD | ||
| 2172 | ALVO Alvotech - Ordinary Shares | 4.95 USD | +1.43% | +3.34% | +38.27% | -41.45% | 1.54 B USD | ||
| 2178 | PAHC Phibro Animal Health Corporation - Class A Common Stock | 37.67 USD | +3.63% | +3.72% | +4.09% | +4.46% | 1.53 B USD |
Frequently asked questions about ANI Pharmaceuticals, Inc.
What is the ANI Pharmaceuticals, Inc. stock price today?
The current price of ANI Pharmaceuticals, Inc. (ANIP) is 72.83. Over the past 24 hours, the stock has changed by -0.93%. Follow the ANIP chart for real-time price dynamics.
What is the stock ticker of ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. trades under the ticker ANIP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ANI Pharmaceuticals, Inc. stock going up?
ANIP has changed by -3.29% over the last week, -8.56% over the last month, and -23.04% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ANI Pharmaceuticals, Inc.?
ANI Pharmaceuticals, Inc. currently has a market capitalization of 1.67 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ANI Pharmaceuticals, Inc. earnings last quarter?
Last quarter, ANI Pharmaceuticals, Inc. reported earnings of 1.09 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ANI Pharmaceuticals, Inc. revenue for the last quarter?
ANI Pharmaceuticals, Inc. reported quarterly revenue of 266.04 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was ANI Pharmaceuticals, Inc. net income for the last quarter?
ANI Pharmaceuticals, Inc. reported net income of 24.71 M for the last quarter. The previous quarter showed 29.49 M, which means net income changed by -16.21%.
How many employees does ANI Pharmaceuticals, Inc. have?
As of the latest available data, ANI Pharmaceuticals, Inc. has 970 employees. Workforce size can provide additional context about the company's scale and operations.
What is ANI Pharmaceuticals, Inc. EBITDA?
ANI Pharmaceuticals, Inc. EBITDA is 76.56 M, and its EBITDA margin is 28.78%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ANI Pharmaceuticals, Inc. stock?
You can buy ANI Pharmaceuticals, Inc. (ANIP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ANI Pharmaceuticals, Inc. stock?
Investing in ANI Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANIP chart and related analysis on metatrader.com as part of your research.